Author:
Osueni Azeberoje,Alasadi Lutfi,Jean-Louis Farla,Sergiy Shurin,Spitalewitz Samuel
Publisher
Springer Science and Business Media LLC
Reference11 articles.
1. The new FDA labeling for ESA--implications for patients and providers;Manns BJ;Clin J Am Soc Nephrol,2012
2. Management of the dialysis patient with sickle cell disease;Boyle SM;Semin Dial,2016
3. The nephropathy of sickle cell trait and sickle cell disease;Ataga KI;Nat Rev Nephrol,2022
4. Chronic organ failure in adult sickle cell disease;Vichinsky E;Hematology Am Soc Hematol Educ Program,2017
5. Cerebrovascular accidents in sickle cell disease: rates and risk factors;Ohene-Frempong K;Blood,1998